Recent Updates
Recently added Catalysts
BWAY Positive Sentiment

Clinical Efficacy of Deep Transcranial Magnetic Stimulation in Psychiatric and Cognitive Disorders: Protocol for a Systematic Review

Key Takeaway: This article outlines a protocol for a systematic review on the clinical efficacy of deep transcranial magnetic stimulation (dTMS) in treating psychiatric and cognitive disorders. The review aims to compare active dTMS with sham treatments and explore subgroup differences. Initial findings indicate a total of 22 eligible articles for inclusion, with ongoing data extraction and quality assessment planned.
Price reaction · baseline $2.49 (2023-11-21 close) · hit pre-market · 8 other BWAY headline(s) in the window, move may be shared
day 0 close
+10.6%
day 1
+17.1%
day 3 · peak
+23.9%

Market Sentiment Analysis

POSITIVE FACTORS

  • Deep TMS shows promise in treating psychiatric and cognitive disorders.
  • The systematic review aims to clarify clinical efficacy and inform treatment decisions.
  • Potential for meta-analysis to provide robust evidence on dTMS effectiveness.

CONCERNS & RISKS

  • Limited understanding of dTMS efficacy compared to sham interventions.
  • The novelty of dTMS means existing literature may be sparse.

Full Press Release Details

Background:

Transcranial magnetic stimulation (TMS) stands as a widely utilized noninvasive technique for brain stimulation in the context of psychiatric and cognitive disorders. In recent times, deep TMS (dTMS) has emerged as an advanced form of TMS capable of reaching deeper brain structures and targeting broader networks. Distinct magnetic Hesed-coil (H-coil) designs, a characteristic feature of dTMS, have been employed to stimulate brain regions associated with the pathophysiology of specific psychiatric and cognitive disorders, thereby yielding therapeutic effects. Due to the relative novelty of dTMS in psychiatry, there is limited understanding of its clinical efficacy across various psychiatric and cognitive disorders—specifically, whether dTMS exhibits superior performance compared to sham or control interventions.

Objective:

This paper delineates a protocol for a systematic review investigating the clinical efficacy of dTMS. The primary objective is to systematically review the literature on dTMS for psychiatric and cognitive disorders and, if feasible, conduct a meta-analysis to compare the efficacy of active dTMS versus sham/control for psychiatric disorders. Additionally, the review will encompass dementia and related cognitive disorders. A secondary objective involves examining subgroup differences (by age, sex, H-coil design, and dTMS parameters [e.g., pulses per session, percentage of motor threshold]) to assess whether dTMS differentially influences clinical outcomes based on these factors.

Methods:

A thorough search of the APA PsycINFO, Embase, MEDLINE, and PubMed databases will be executed using keywords such as “H-coil” and “dTMS.” Two authors (AD and MD) will be responsible for screening relevant articles, assessing article eligibility based on predetermined inclusion and exclusion criteria, and extracting data. All included articles will undergo a quality and risk of bias assessment. A qualitative summary of data from included articles will be presented in the systematic review. If a sufficient number of comparable studies are available, a meta-analysis will be conducted to (1) determine the effect of active versus sham dTMS (or another control arm) across psychiatric and cognitive disorders, and (2) explore subgroup effects on clinical outcomes.

Results:

The preliminary search yielded a total of 1134 articles from APA PsycINFO, Embase, and MEDLINE databases. After full-text screening, 21 eligible articles remained, with an additional article identified from the references section of an existing systematic review. In total, 22 eligible articles were included, and ongoing procedures involve data extraction and quality assessment.

Conclusions:

This systematic review will delineate the evidence regarding the clinical efficacy of dTMS across various psychiatric and cognitive disorders. The results will offer clinicians valuable insights into both clinical (e.g., participant age, sex, psychiatric or cognitive disorder) and methodological factors (e.g., H-coil design, dTMS parameters) that may contribute to dTMS efficacy. This information may assist clinicians in making informed decisions about prescribing dTMS for specific psychiatric and cognitive disorders.

Frequently Asked Questions

What is the focus of the systematic review?

The review focuses on the clinical efficacy of deep TMS in psychiatric and cognitive disorders.

How many articles were included in the review?

A total of 22 eligible articles were included after screening.

What will the review compare?

It will compare the efficacy of active dTMS versus sham or control interventions.

What factors will be examined in the review?

The review will examine factors like age, sex, H-coil design, and dTMS parameters.

What databases will be searched for articles?

The search will include APA PsycINFO, Embase, MEDLINE, and PubMed.

Last updated: Nov 22, 2023